• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: NOVOCURE GMBH OPTUNE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

NOVOCURE GMBH OPTUNE Back to Search Results
Model Number TFH9100
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Wound Dehiscence (1154)
Event Date 03/02/2023
Event Type  Injury  
Manufacturer Narrative
Novocure opinion is that the contribution of the array placement to wound dehiscence cannot be ruled out.Wound dehiscence was reported as an adverse event in the ef-14 trial of optune together with temozolomide (tmz) compared to tmz alone in patients with newly diagnosed gbm in the optune/tmz arm of the trial (<1%) only.
 
Event Description
A 70-year old female patient with newly diagnosed glioblastoma (gbm) started optune therapy on (b)(6) 2022.On (b)(6), 2023, the spouse reported the patient had a non-healing wound, behind the left ear in the location of the previous surgical resection site (last surgical resection: unknown).Upon removal of the transducer arrays on the same day, cranial hardware (screw) was noted.Patient was advised to temporarily discontinue optune therapy.The healthcare provider reported the neurosurgeon was aware and surgical intervention might be required to remove the cranial hardware to allow the wound to heal.Reportedly, since the wound improved, the patient restarted optune therapy.After restarting the condition of the wound worsened.During a visit with the neurosurgeon on (b)(6) 2023, it was determined surgery was required to remove the hardware.The neurosurgeon advised discontinuing optune therapy.No causality assessment was provided by the prescribing physician.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
OPTUNE
Type of Device
OPTUNE
Manufacturer (Section D)
NOVOCURE GMBH
business village d4
park 6/platz 10
root d4, 6039
SZ  6039
Manufacturer (Section G)
NOVOCURE GMBH
business village d4
park 6/platz 10
root d4, 6039
SZ   6039
Manufacturer Contact
sharon perez
195 commerce way
portsmouth, NH 03801
2077527602
MDR Report Key16617272
MDR Text Key312010464
Report Number3010457505-2023-00230
Device Sequence Number1
Product Code NZK
Combination Product (y/n)N
Reporter Country CodeSW
PMA/PMN Number
P100034
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Consumer
Reporter Occupation Other
Type of Report Initial
Report Date 03/27/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received03/27/2023
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Lay User/Patient
Device Model NumberTFH9100
Device Catalogue NumberTFH9100EU
Device Lot NumberN/A
Date Manufacturer Received03/02/2023
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured11/16/2021
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Reuse
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age70 YR
Patient SexFemale
-
-